Rheumatoid Arthritis Clinical Trial
Official title:
The Medacta International GMK Sphere Post-Marketing Surveillance Study
Verified date | December 2023 |
Source | Medacta International SA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a Post-Marketing Surveillance of GMK Sphere knee prosthesis.
Status | Active, not recruiting |
Enrollment | 500 |
Est. completion date | October 2029 |
Est. primary completion date | October 2029 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - A disabled or severely disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis, poly-arthritis or avascular necrosis - Patients must be between the age of 18 and 80 at the time of consent - Listed for total knee replacement surgery. - Patients who are willing to give informed written consent Exclusion Criteria: - Progressive local or systemic infection - Muscular loss, neuromuscular disease or vascular deficiency of the affected limb, making the operation unjustifiable - Severe instability secondary to advance destruction of condylar structures or loss of integrity of the medial or lateral ligament - Any patient who cannot or will not provide informed consent for participation in the study - Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems - Patient whose BMI exceeds 40 - Any case not described in the inclusion criteria |
Country | Name | City | State |
---|---|---|---|
Belgium | AZ Maria Middelares | Gent | |
United Kingdom | The Elective Orthopaedic Centre (EOC) | Epsom | Surrey |
United Kingdom | Royal National Orthopaedic Hospital NHS Trust | Stanmore | Middlesex |
United Kingdom | Royal London Hospital | Whitechapel | London |
Lead Sponsor | Collaborator |
---|---|
Medacta International SA |
Belgium, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the clinical outcome following total knee replacement using the Knee Society Score. | 6 months | ||
Secondary | The OXFORD score as a measure of implant functionality. | pre-op, 6 months and annually for 10 years | ||
Secondary | Assessment of implant survivorship as a measure of safety and tolerability. | 6 weeks, 6 months, 3, 5, 7 and 10 years. | ||
Secondary | Radiographic analysis | pre-op, 6 months, 3, 5,7 and 10 years. | ||
Secondary | The EuroQol score as a measure of patient' quality of life. | pre-op, 6 months, 3, 5,7 and 10 years | ||
Secondary | Assessment of the clinical outcome following total knee replacement using the Knee Society Score | pre-op, at 6 months, at 3, 5, 7 and 10 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |